Tadao Shibanuma is a prominent inventor based in Saitama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial agents. With a total of 12 patents to his name, Shibanuma's work has had a considerable impact on medical science.

Latest Patents

Among his latest patents, Shibanuma has developed a series of cephalosporin derivatives. One notable patent includes a 7-[2-(2-amino-4-thiazolyl)-2-(hydroxyimino)-acetamido]-3-(1,3-dithiolan-2-yl)-3-cephem-4-carboxylic acid derivative. This compound can be represented by a specific general formula, wherein A can represent various groups such as a hydrogen atom or different acetoxyethyl groups. Additionally, he has worked on amino-3-substituted-methyl-3-cephem-4-carboxylic acids and their lower alkylsily derivatives. These compounds are valuable intermediates in the preparation of new antibacterial agents, and he has devised a new process for their preparation.

Career Highlights

Shibanuma is currently associated with Yamanouchi Pharmaceutical Company Ltd., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing the development of effective antibacterial treatments.

Collaborations

Throughout his career, Tadao Shibanuma has collaborated with notable colleagues, including Noriaki Nagano and Masaru Iwanami. These collaborations have further enriched his research and development efforts.

Conclusion

Tadao Shibanuma's contributions to the field of antibacterial agents through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence the pharmaceutical industry and improve healthcare outcomes.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]